During bone metastasis of prostate cancer, osteoblasts and BMECs stimulated by prostate-derived parathyroid hormone-related protein increase the secretion of CCL2 that could enhance osteoclastic activity and prostate cancer growth in bone [78,153]. The gene discussed is CCL2; the disease is prostate cancer.